SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028572
Filing Date
2018-11-08
Accepted
2018-11-08 16:20:05
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20180930.htm 10-Q 1950032
2 EX-31.1 aimt-ex311_6.htm EX-31.1 19449
3 EX-31.2 aimt-ex312_9.htm EX-31.2 19452
4 EX-32.1 aimt-ex321_7.htm EX-32.1 16893
5 GRAPHIC gipelkpke3wo000001.jpg GRAPHIC 25238
  Complete submission text file 0001564590-18-028572.txt   5900716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aimt-20180930.xml EX-101.INS 1315663
7 XBRL TAXONOMY EXTENSION SCHEMA aimt-20180930.xsd EX-101.SCH 35178
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20180930_cal.xml EX-101.CAL 30621
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20180930_def.xml EX-101.DEF 92223
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20180930_lab.xml EX-101.LAB 274347
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20180930_pre.xml EX-101.PRE 203502
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 181169955
SIC: 2834 Pharmaceutical Preparations